258 related articles for article (PubMed ID: 33258480)
1. The mechanisms of skeletal muscle atrophy in response to transient knockdown of the vitamin D receptor in vivo.
Bass JJ; Kazi AA; Deane CS; Nakhuda A; Ashcroft SP; Brook MS; Wilkinson DJ; Phillips BE; Philp A; Tarum J; Kadi F; Andersen D; Garcia AM; Smith K; Gallagher IJ; Szewczyk NJ; Cleasby ME; Atherton PJ
J Physiol; 2021 Feb; 599(3):963-979. PubMed ID: 33258480
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the vitamin D receptor (VDR) induces skeletal muscle hypertrophy.
Bass JJ; Nakhuda A; Deane CS; Brook MS; Wilkinson DJ; Phillips BE; Philp A; Tarum J; Kadi F; Andersen D; Garcia AM; Smith K; Gallagher IJ; Szewczyk NJ; Cleasby ME; Atherton PJ
Mol Metab; 2020 Dec; 42():101059. PubMed ID: 32771696
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor.
Gopinath SD
Skelet Muscle; 2017 Jan; 7(1):2. PubMed ID: 28122601
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 Exerts Beneficial Effects on C2C12 Myotubes through Activation of the Vitamin D Receptor (VDR)/Sirtuins (SIRT)1/3 Axis.
Talib NF; Zhu Z; Kim KS
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004107
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D/Vitamin D Receptor Signaling Attenuates Skeletal Muscle Atrophy by Suppressing Renin-Angiotensin System.
Li WX; Qin XH; Poon CC; Wong MS; Feng R; Wang J; Lin FH; Sun YL; Liu SF; Wang YJ; Zhang Y
J Bone Miner Res; 2022 Jan; 37(1):121-136. PubMed ID: 34490953
[TBL] [Abstract][Full Text] [Related]
6. The vitamin D receptor regulates mitochondrial function in C2C12 myoblasts.
Ashcroft SP; Bass JJ; Kazi AA; Atherton PJ; Philp A
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C536-C541. PubMed ID: 31940245
[TBL] [Abstract][Full Text] [Related]
7. Systemic ablation of vitamin D receptor leads to skeletal muscle glycogen storage disorder in mice.
Das A; Gopinath SD; Arimbasseri GA
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):467-480. PubMed ID: 34877816
[TBL] [Abstract][Full Text] [Related]
8. Myogenic, genomic and non-genomic influences of the vitamin D axis in skeletal muscle.
Bollen SE; Atherton PJ
Cell Biochem Funct; 2021 Jan; 39(1):48-59. PubMed ID: 33037688
[TBL] [Abstract][Full Text] [Related]
9. Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function.
Girgis CM; Cha KM; So B; Tsang M; Chen J; Houweling PJ; Schindeler A; Stokes R; Swarbrick MM; Evesson FJ; Cooper ST; Gunton JE
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1228-1240. PubMed ID: 31225722
[TBL] [Abstract][Full Text] [Related]
10. The Vitamin D/Vitamin D receptor (VDR) axis in muscle atrophy and sarcopenia.
Bollen SE; Bass JJ; Fujita S; Wilkinson D; Hewison M; Atherton PJ
Cell Signal; 2022 Aug; 96():110355. PubMed ID: 35595176
[TBL] [Abstract][Full Text] [Related]
11. Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.
Hosoyama T; Kawai-Takaishi M; Iida H; Yamamoto Y; Nakamichi Y; Watanabe T; Takemura M; Kato S; Uezumi A; Matsui Y
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):907-918. PubMed ID: 38533539
[TBL] [Abstract][Full Text] [Related]
12. VDR regulates simulated microgravity-induced atrophy in C2C12 myotubes.
Yuzawa R; Koike H; Manabe I; Oishi Y
Sci Rep; 2022 Jan; 12(1):1377. PubMed ID: 35082348
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific deletion of the vitamin D receptor in mice is associated with diaphragm muscle weakness.
Fogarty MJ; Losbanos LL; Craig TA; Reynolds CJ; Brown AD; Kumar R; Sieck GC
J Appl Physiol (1985); 2021 Jul; 131(1):95-106. PubMed ID: 34013750
[TBL] [Abstract][Full Text] [Related]
14. FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle.
Chen S; Villalta SA; Agrawal DK
J Bone Miner Res; 2016 Mar; 31(3):585-95. PubMed ID: 26462119
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells.
Girgis CM; Clifton-Bligh RJ; Mokbel N; Cheng K; Gunton JE
Endocrinology; 2014 Feb; 155(2):347-57. PubMed ID: 24280059
[TBL] [Abstract][Full Text] [Related]
16. Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cells.
Antinozzi C; Corinaldesi C; Giordano C; Pisano A; Cerbelli B; Migliaccio S; Di Luigi L; Stefanantoni K; Vannelli GB; Minisola S; Valesini G; Riccieri V; Lenzi A; Crescioli C
J Steroid Biochem Mol Biol; 2017 Mar; 167():169-181. PubMed ID: 28042053
[TBL] [Abstract][Full Text] [Related]
17. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors.
Endo I; Inoue D; Mitsui T; Umaki Y; Akaike M; Yoshizawa T; Kato S; Matsumoto T
Endocrinology; 2003 Dec; 144(12):5138-44. PubMed ID: 12959989
[TBL] [Abstract][Full Text] [Related]
18. Dystrobrevin alpha gene is a direct target of the vitamin D receptor in muscle.
Tsoumpra MK; Sawatsubashi S; Imamura M; Fukumoto S; Takeda S; Matsumoto T; Aoki Y
J Mol Endocrinol; 2020 Apr; 64(3):195-208. PubMed ID: 31940280
[TBL] [Abstract][Full Text] [Related]
19. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation.
Srikuea R; Zhang X; Park-Sarge OK; Esser KA
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C396-405. PubMed ID: 22648952
[TBL] [Abstract][Full Text] [Related]
20. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers.
Girgis CM; Mokbel N; Cha KM; Houweling PJ; Abboud M; Fraser DR; Mason RS; Clifton-Bligh RJ; Gunton JE
Endocrinology; 2014 Sep; 155(9):3227-37. PubMed ID: 24949660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
